Ownership issues in autologous stem cell therapies

Research output: Contribution to journalArticlepeer-review

Abstract

The growing industry of unproven stem cell therapies has focused on using autologous cells in order to enable patients to benefit from medical treatment by their own cells. This article will explore the various judicial interpretations of the ownership rights of biological materials and suggests that patients may have property rights over their own stem cells based on the courts' decisions in recent cases.
Original languageEnglish
Pages (from-to)186-191
Number of pages6
JournalEubios Journal of Asian and International Bioethics
Volume29
Issue number6
Publication statusPublished - 2019

Keywords

  • stem cells
  • law and legislation

Fingerprint

Dive into the research topics of 'Ownership issues in autologous stem cell therapies'. Together they form a unique fingerprint.

Cite this